Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Phase II results reported for Bexxar

Dec. 15, 1997

Cel-Sci expands Multikine trial

Dec. 12, 1997

New data on PDL's SMART M195 antibody reported

Dec. 12, 1997

FDA approves Neoprobe's IND for RIGS/ACT therapy

Dec. 11, 1997

ImmunoGen's C242-DM1 found safe in preclinical studies

Dec. 10, 1997

ImClone and Merck KGaA expand collaboration for BEC2 cancer vaccine

Dec. 10, 1997

Ono-4007: antitumor lipid A analogue that enhances TNF production by macrophages

Dec. 10, 1997

StressGen prepares to evaluate Oncocine in clinical trials

Dec. 9, 1997

Seragen submits BLA for CTCL biological product

Dec. 9, 1997

IL-12 for treatment of malignant tumors

Dec. 8, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 24, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...
In the clinic for June 22, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Alkermes, Boehringer, Cambrian, F2G, Intrabio, Lexeo, Memo, Novocure,...